Coya Therapeutics, Inc.
COYA • NASDAQ
Coya Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Arun Swaminathan, with a market cap of $92.9M.
CEOArun Swaminathan
Next Earnings
Upcoming earnings announcement for Coya Therapeutics, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.39
Revenue Estimate
$71.7K
Earnings History
Past 12 earnings reports for Coya Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$0.34Est: -$0.21 | -61.9% | $4.0MEst: $3.1M | +27.1% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.13Est: -$0.17 | +23.5% | $3.6MEst: $5.6M | -36.1% | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.36Est: -$0.35 | -2.9% | $163.6KEst: $2.1M | -92.1% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.44Est: -$0.12 | -266.7% | $257.9KEst: $2.6M | -90.2% | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$0.18 | — | $2.0M | — | 10-K/A |
| Nov 6, 2024 | Q3 2024 | -$0.26Est: -$0.41 | +36.6% | -Est: $170.0K | -100.0% | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.19Est: -$0.14 | -35.7% | $3.4MEst: $3.9M | -12.2% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.35Est: -$0.30 | -16.7% | $126.8K | — | 10-Q |
| Mar 19, 2024 | Q4 2023 | $0.15 | — | $6.0M | — | 10-K |
| Nov 8, 2023 | Q3 2023 | -$0.34 | — | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.31 | — | - | — | — |
| May 10, 2023 | Q1 2023 | -$0.28 | — | - | — | — |